CAS 68377-91-3
:Arotinolol hydrochloride
Description:
Arotinolol hydrochloride is a pharmaceutical compound primarily recognized for its role as a non-selective beta-adrenergic antagonist with additional alpha-adrenergic blocking properties. It is often utilized in the treatment of hypertension and certain cardiovascular conditions. The substance is characterized by its ability to lower blood pressure by inhibiting the effects of catecholamines on the heart and blood vessels, leading to decreased heart rate and vascular resistance. Arotinolol hydrochloride is typically administered in its hydrochloride salt form, which enhances its solubility and bioavailability. The compound is known to exhibit a moderate half-life, allowing for effective dosing regimens. In terms of safety and side effects, it may cause typical beta-blocker-related reactions, such as fatigue, dizziness, or bradycardia. As with many pharmaceuticals, its use should be monitored by healthcare professionals to manage potential interactions and contraindications effectively. Overall, Arotinolol hydrochloride represents a significant therapeutic option in the management of cardiovascular diseases.
Formula:C15H21N3O2S3·ClH
InChI:InChI=1S/C15H21N3O2S3.ClH/c1-15(2,3)17-6-9(19)7-21-14-18-10(8-22-14)11-4-5-12(23-11)13(16)20;/h4-5,8-9,17,19H,6-7H2,1-3H3,(H2,16,20);1H
InChI key:InChIKey=XXDAXBZYUXLDRD-UHFFFAOYSA-N
SMILES:C(N)(=O)C=1SC(=CC1)C=2N=C(SCC(CNC(C)(C)C)O)SC2.Cl
Synonyms:- 2-Thiophenecarboxamide, 5-[2-[[3-[(1,1-dimethylethyl)amino]-2-hydroxypropyl]thio]-4-thiazolyl]-, hydrochloride (1:1)
- 2-Thiophenecarboxamide, 5-[2-[[3-[(1,1-dimethylethyl)amino]-2-hydroxypropyl]thio]-4-thiazolyl]-, monohydrochloride
- 2-Thiophenecarboxamide, 5-[2-[[3-[(1,1-dimethylethyl)amino]-2-hydroxypropyl]thio]-4-thiazolyl]-, monohydrochloride, (S)-
- 5-(2-{[3-(Tert-Butylamino)-2-Hydroxypropyl]Sulfanyl}-1,3-Thiazol-4-Yl)Thiophene-2-Carboxamide
- Almarl
- Arotinolol Hcl
- S 596
- Arotinolol hydrochloride
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 7 products.
Arotinolol hydrochloride
CAS:<p>Arotinolol HCl is a non-selective α/β-blocker, anti-hypertensive, anti-obesity, and improves aortic stiffness.</p>Formula:C15H22ClN3O2S3Purity:99.84%Color and Shape:SolidMolecular weight:408Arotinolol HCl
CAS:Formula:C15H21N3O2S3·HClColor and Shape:White To Off-White SolidMolecular weight:371.53 36.46Arotinolol Hydrochloride
CAS:Controlled Product<p>Applications Arotinolol is both and alpha- and beta-adrenoceptor antagonist and is used to treat essential tremors and hypertension.<br>References Kuroda, Y., et al.: Neurology, 38, 650 (1988); Miyagishi, A., et al.: Arch. Pharmacodyn. Ther., 271, 249 (1984); Wu, H., et al.: Hypertens. Res.: Off. J. Jpn. Soc. Hypertens., 24, 605 (2001)<br></p>Formula:C15H21N3O2S3·ClHColor and Shape:NeatMolecular weight:408.002Arotinolol hydrochloride
CAS:<p>Arotinolol hydrochloride is a beta-blocker that, in contrast to propranolol, has a higher selectivity for the β1 receptor. It is used to treat hypertension and angina pectoris. Arotinolol hydrochloride lowers blood pressure by inhibiting the activity of α-adrenergic receptors, which are found in the heart and vascular smooth muscle. This inhibition reduces the release of norepinephrine and causes vasodilation. Arotinolol hydrochloride also has a positive effect on cardiac function as it decreases myocardial oxygen demand and increases coronary flow. Arotinolol hydrochloride has been shown to lower systolic pressure in anesthetized dogs with an intravenous dose of sodium citrate. The drug also lowers diastolic pressure in conscious dogs at doses of 0.5 mg/kg (0.2 mg/lb) or greater when given intravenously or subcutaneously.</p>Formula:C15H22ClN3O2S3Purity:Min. 98%Color and Shape:PowderMolecular weight:408 g/molRef: 3D-FA146940
Discontinued product






